Finished vitamin and provitamin preparations packaged for direct consumer or clinical use—including single-nutrient and multi-vitamin formulations—are classified under SITC 54292 when presented in dosage form or retail packings. The regulatory treatment at US entry depends heavily on how the product is labeled: a vitamin supplement marketed with structure/function claims is regulated by FDA as a dietary supplement, while the same compound presented with disease-treatment claims may be classified as a drug, triggering a more stringent admissibility pathway. This labeling-driven regulatory fork is a common compliance challenge for importers sourcing finished vitamin products internationally. Importers should verify FDA classification of the specific product before shipment; consult a licensed customs broker or regulatory specialist for guidance.

AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.